pan Ras (C-4) Antibody sc-166691 from Santa Cruz Biotechnology, Inc.

Product Specs
Itempan Ras (C-4) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-166691
Antibody TypePrimary Antibodies
NCBI Gene Aliasesc-H-ras, Kras2, c-rasHa, RASH1, ARH9, C-H-RAS, HAMSV, ras, 'C-K-RAS, ALPS4, HRAS1, K-ras, C-BAS/HAS, c-Ki-ras, KI-RAS, C-K-RAS, NCMS, Ha-ras, c-K-ras, K-Ras 2, K-Ras, Hras-1, p21B, H-ras, Ki-ras, K-RAS4A, NRAS1, N-ras, K-RAS4B, RASK2, K-RAS2B, K-RAS2A, H9, p21ras, CTLO, NS3, Harvey-ras, NS6, KRAS, Kras-2, NS, KRAS1, KRAS2, CMNS, OES, CFC2, C-HA-RAS1, c-Ha-ras, Hras1, ARHC, RHOH9, RALD, c-Ki-ras2, H-RASIDX
CloneC-4
Quantity200 µg/ml
ApplicationsWB, IP, IF, IHC(P), ELISA
Conjugate/TagUnconjugated
FormatPurified
Reactivitymouse, rat, human
Hostmouse
ClonalityMonoclonal
NCBI Full Gene NameNRAS proto-oncogene, GTPase, neuroblastoma ras oncogene, Harvey rat sarcoma virus oncogene, Kirsten rat sarcoma viral oncogene homolog, HRas proto-oncogene, GTPase, ras homolog family member C, KRAS proto-oncogene, GTPase
TargetN-Ras
IsotypeIgG2b

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented ConditionsOncology ResearchApril 22, 2026Chanwoong Yoon, Euihyeon Na, Min Joo Choi, Sang-Pil YoonAkt (#sc-7985),1:1000 Primary antibodies,"Santa Cruz Biotechnology (Santa Cruz, CA, USA)",Pan-Ras (#sc-166691),1:1000 Primary antibodies,"Santa Cruz Biotechnology (Santa Cruz, CA, USA)",Sox2 (#sc-365823),1:1000 ,CD44

(2) CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responsesiScienceJune 20, 2025Petros Kechagioglou, Hajime Yurugi, Camille Dupont, Alexey Chernobrovkin, Rossana Romero, Gregory Harms, Marie Oster, Sandra Ciesek, Rebecca Tweedell, Thirumala-Devi Kanneganti, et al.SAPK/JNK (#9252) and Caspase-3 (#9662) were purchased from Cell Signaling Technology. Anti-pan RAS (sc-166691), anti-GST (sc-138) and anti-SOS1 (sc-17793) antibodies were purchased from Santa Cruz. Antibodies directed

(3) The feasible role of soluble E‑cadherin in spheroidogenesis of HCT116 colorectal cancer cells, a candidate biomarker for liquid biopsyOncology LettersMarch 24, 2025In-Youb Chang, Hye-Jin Boo, Jin Won Hyun, Sang-Pil Yoon(ab52894),Abcam,Primary antibody ERK (sc-93); β-catenin (sc-7199);,Santa Cruz Biotechnology,Primary antibody pan-RAS (sc-166691); β-actin (sc-47778);,, GAPDH (sc-47724),, Anti-mouse IgG (PI-2000); anti-rabbit IgG (PI-1000),Vector Laboratories

(4) Probing RAS Function Using Monobody and NanoBiT TechnologiesMethods in Molecular BiologyNovember 30, 2024Michael Whaby, Rakesh Sathish Nair, John P. O’BryanVWR) Pierce™ BCA Protein Assay Kit (Cat # 23225, ThermoFisher) Anti pan Ras Antibody (C-4) (Cat # sc-166691, Santa Cruz Biotechnology,) Anti mouse MYC (Cat # 05–724, Clone A46, Millipore-Sigma) Anti-HA monoclonal

(5) Two Main Cancer Biomarkers as Molecular Targets of Binase Antitumor ActivityBioMed Research InternationalFebruary 12, 2024Elena Dudkina, Vera Ulyanova, Violetta Asmandiyarova, Valentina Vershinina, Olga Ilinskayaovernight. In the case of ROSE 199 A2/5, 1 μg primary mouse monoclonal antibodies against pan Ras (sc-166691; Santa Cruz, USA) instead of anti-EGFR antibodies were added. The immunocomplexes were precipitated

(6) An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stressNature communicationsAugust 17, 2023Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, Yoshida T, Yoshida Y, Takamatsu N, Yoshimi A, et al.diluted in 5% skim milk in TBST (supplemented with 0.02% of NaN3): anti-pan-RAS (1:1000, Santa Cruz, Cat# sc-166691), anti-αTubulin (1:5000, MBL, Cat# PM054), anti-phospho-ATR (Thr1989) (1:3000, Cell Signaling Technology,

(7) Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patientsMolecular and cellular biochemistryJune 1, 2023Tripathi K, Maurya N, Goel A, Singhai A, Garg M.

(8) Increased soluble E‑cadherin of spheroid formation supplemented with fetal bovine serum in colorectal cancer cellsOncology lettersMay 1, 2023Chang IY, Yoon SP.1:1,000; cat. no. sc-9166), Oct3/4 (C-10; 1:1,000; cat. no. sc-5279), Pan-Ras (C-4; 1:1,000; cat. no. sc-166691), Sox2 (E-4; 1:1,000; cat. no. sc-365823) and Wilms tumor protein [WT1 (6F-H17); 1:1,000; cat. no. sc-81619]

(9) Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-modelsFrontiers in oncologyJanuary 1, 2023Kaehler M, Osteresch P, Künstner A, Vieth SJ, Esser D, Möller M, Busch H, Vater I, Spielmann M, Cascorbi I, et al.

(10) HSPB8 counteracts tumor activity of BRAF- and NRAS-mutant melanoma cells by modulation of RAS-prenylation and autophagyCell death & diseaseNovember 18, 2022Cristofani R, Piccolella M, Montagnani Marelli M, Tedesco B, Poletti A, Moretti RM.anti-BRAFV600E (RM8) was from RevMAb Biosciences (San Francisco, CA, USA). Mouse anti-pan-RAS (C-4) (sc-166691) was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-LC3 (L8918) and mouse anti-alpha-tubulin

(11) Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1PharmaceuticsAugust 9, 2022Choe EJ, Lee CH, Bae JH, Park JM, Park SS, Baek MC.Cell Signaling Technology), Rab27a (ab55667, Abcam), Rab11 (ab18211, Abcam), Rab7 (ab50533, Abcam), pan Ras (sc-166691, Santa Cruz, Santa Cruz, CA, USA), Rap1A (sc-398755, Santa Cruz), p-B-Raf (2696S, Cell Signaling Technology),

(12) Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancerNature communicationsJuly 26, 2022Bartolacci C, Andreani C, Vale G, Berto S, Melegari M, Crouch AC, Baluya DL, Kemble G, Hodges K, Starrett J, et al.

(13) CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological DifferentiationNon-coding RNAJune 6, 2022Kato Y, Tago K, Fukatsu S, Okabe M, Shirai R, Oizumi H, Ohbuchi K, Yamamoto M, Mizoguchi K, Miyamoto Y, et al.(ACE) 2,Santa Cruz Biotechnology,sc-390851,F2520,"IB, 1/500" Anti-pan-Ras,Santa Cruz Biotechnology,sc-166691,H1220,"IB, 1/500" Anti-green fluorescence protein (GFP),Nacalai Tesque,04404-84,M7H8151,"immunoprecipitation,

(14) BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumorPloS oneJanuary 1, 2022Yu T, Shi Y, Pan X, Feng Q, Wang P, Song S, Yang L, Yang J.

(15) Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancerPloS oneJanuary 1, 2022Tucker JD, Doddapaneni R, Lu PJ, Lu QL.onto supported nitrocellulose membrane. Immunoblots were probed with anti-pan Ras C-4 primary antibody sc-166691 (Santa Cruz) or anti-KRAS primary antibody 12063-1-AP (Proteintech) at 1:1000 dilution in 3% nonfat

(16) Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1Molecular oncologyOctober 1, 2021Kandasamy P, Zlobec I, Nydegger DT, Pujol-Giménez J, Bhardwaj R, Shirasawa S, Tsunoda T, Hediger MA.Sigma‐Aldrich, USA. Mouse monoclonal antibodies against YAP (Cat. no. sc‐271134), pan‐Ras (Cat. no. sc‐166691), KRAS (Cat. no. sc‐30), and β‐Actin were purchased from Santa Cruz Biotechnology (Heidelberg, Germany).

(17) Interaction between Ras and Bcl2L12 in B cells suppresses IL-10 expressionClinical immunology (Orlando, Fla.)August 1, 2021Li J, Yang G, Luo XQ, Mo LH, Qiu SY, Yang LT, Liu DB, An YF, Yang PC.

(18) Selective and noncovalent targeting of RAS mutants for inhibition and degradationNature communicationsMay 11, 2021Teng KW, Tsai ST, Hattori T, Fedele C, Koide A, Yang C, Hou X, Zhang Y, Neel BG, O'Bryan JP, et al.

(19) ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesisCancer gene therapyMay 1, 2021Bogucka K, Marini F, Rosigkeit S, Schloeder J, Jonuleit H, David K, Schlackow M, Rajalingam K.

(20) RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480BMC cancerMarch 25, 2021Huang CC, Liu FR, Feng Q, Pan XY, Song SL, Yang JL.

Be the First to Write a Review!

pan Ras (C-4) Antibody

pan Ras (C-4) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (45)

Reviews

pan Ras (C-4) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map